Clinical research
Omalizumab reduces colds in children with asthma
Children treated with omalizumab had 27% fewer colds then those treated with guideline-based care.
Omalizumab, a biologic that targets immunoglobulin E (IgE), can reduce viral-induced asthma exacerbations in patients with allergic asthma. However, little is known about its effect on colds.
Researchers randomly assigned 478 children (aged 6–17 years) with allergic asthma to receive guideline-based care only or guideline-based care plus fluticasone or omalizumab. Treatment took place over four months during autumn, when colds are more common.
Children treated with omalizumab had 27% fewer colds than children assigned to guideline-based care. This reduction was observed in both those with moderate and severe-persistent asthma. In contrast, fluticasone had no effect on cold rates.
The researchers, who reported their results at a conference in Los Angeles, California, on 4–7 March 2016[1], say the findings support the idea that by reducing IgE levels, omalizumab increases interferon responses, leading to better protection against viruses.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200892
Recommended from Pharmaceutical Press
- Previous
- Next
BNF and British National Formulary for Children
Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£138.50Buy now
BNF and British National Formulary for Children
Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£262.50Buy now
Patient Care in Community Practice
Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.
£22.00Buy now
Paediatric Drug Handling
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.
£33.00Buy now
Introduction to Renal Therapeutics
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.
£38.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.